Mounjaro®
Starting from £179.99/mo
Start journey Learn moreTaking semaglutide at home is straightforward for most people — once a week, one injection from a pre-filled pen, at a time that suits your routine. Wegovy is the brand licensed in the UK for weight management, and the process from first prescription to settled home routine follows a clear clinical sequence. These are prescription-only medicines, so a prescriber assesses suitability before any treatment begins.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Before the pen arrives, it helps to think about where it will live. The fridge door is a natural spot, cold, accessible and a reliable reminder when you open it for breakfast. Semaglutide pens must be kept refrigerated at 2–8°C until you use them; check the patient information leaflet for the brief window they can spend at room temperature when travelling, because that window is shorter than most people assume.
Your prescriber will have confirmed the injection sites: abdomen (at least a few centimetres from the navel), upper thigh or upper arm. Rotating between these each week keeps tissue healthy over the long term. You'll also want a sharps bin to hand, disposing of used needles in household rubbish is unsafe and illegal. Our FAQs cover common preparation questions if you want to read ahead.
A short run-through of the pen itself takes less than two minutes. The cap comes off, the pen goes against the skin at a 90-degree angle, and you press until the injection is complete, no self-timing required. The full Wegovy guide walks through the clinical detail of the device if you'd like more context before you start.
The standard Wegovy titration runs from 0.25 mg up through 0.5 mg, 1.0 mg, 1.7 mg and finally 2.4 mg, with roughly four weeks at each step. That pace exists for a reason: semaglutide slows gastric emptying, and the gastrointestinal side effects (nausea, loose stools, indigestion) are most pronounced when the dose jumps too quickly. Climbing in stages gives your gut time to adapt.
Most people find the 0.25 mg and 0.5 mg weeks relatively comfortable. Nausea tends to peak in the first day or two after an injection and then settles. Eating smaller portions, avoiding rich or fatty food on injection day and staying well hydrated all help. If side effects feel unmanageable, contact your prescriber rather than skipping doses unilaterally, adjusting the titration pace is sometimes the right answer. Semaglutide and digestive side effects has a fuller picture of what's typical versus what needs clinical attention.
The NHS patient-level page for semaglutide on NHS.uk lists the complete side-effect profile and urgent warning signs, it's worth bookmarking alongside your leaflet.
Most people reach 2.4 mg after around four to five months. At maintenance, the weekly rhythm becomes second nature: same day, same rough time, brief self-injection, pen back in the fridge. The appointment overhead is low compared with clinic-based treatments.
A few things matter at this stage. Your prescriber should review your progress before every repeat prescription, at a regulated pharmacy that review is clinical, not automatic. Weight, tolerability and any new health information are all factors. If you've transferred from another provider, or are considering doing so, our semaglutide treatment overview explains how evidence-based transfer works and what documentation is typically needed.
For context on what treatment typically costs in the UK private market, the Wegovy price comparison page breaks down what different providers include and what headline figures often leave out, useful reading before committing to any service.
Home treatment does not mean unsupported treatment. There are specific situations where you should stop injecting and contact a healthcare professional promptly: severe or persistent stomach pain that spreads to the back (a signal the pancreas may be involved), signs of an allergic reaction, significant swelling or pain at injection sites, or symptoms of gallbladder trouble such as sudden pain in the upper right abdomen. The MHRA issued a Drug Safety Update in January 2026 specifically highlighting acute pancreatitis as a known, though infrequent, risk with GLP-1 medicines, the key message being that persistent stomach pain deserves prompt medical assessment, not waiting to see if it passes.
Pregnancy, breastfeeding and trying to conceive are situations where semaglutide should not be used. If any of those apply, tell your prescriber before starting or at your next review. Under-18s are not covered by the licence either. These aren't small-print caveats, they're the basis on which the prescriber makes their decision each time. It is also worth being aware that searches around how to make semaglutide at home turn up unregulated methods that carry serious safety risks, which is why understanding what a legitimate semaglutide at home kit from a regulated pharmacy actually includes can help you tell the difference. If you have questions about what weight-loss treatment is right for your situation, that conversation starts at the consultation, not after the pen arrives.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.